SEC 13F Intelligence

E. Ohman J:Or Asset Management AB / CYTK

E. Ohman J:Or Asset Management AB’s Cytokinetics Inc Position

Does E. Ohman J:Or Asset Management AB own Cytokinetics Inc (CYTK)? Yes — 300.8K shares worth $20M (+0.52% of its 13F portfolio) as of Q1 2026, down from 363.0K shares the prior filed quarter.

Position Value
$20M
Q1 2026
Shares
300.8K
% of Portfolio
+0.52%
Quarters Held
5
currently held

Position History CYTK

Reported value by quarter
Q1 ’25: $13MQ1 ’25Q2 ’25: $13MQ2 ’25Q3 ’25: $22MQ3 ’25Q4 ’25: $23MQ4 ’25Q1 ’26: $20MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026300.8K$20M+0.52%
Q4 2025363.0K$23M+0.54%
Q3 2025407.0K$22M+0.53%
Q2 2025407.0K$13M+0.33%
Q1 2025329.2K$13M+0.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See E. Ohman J:Or Asset Management AB’s full portfolio or all institutional holders of CYTK.